CME Group Inc.

CME Financial Services · Financial Data & Stock Exchanges
Delayed 15 min
Last close
$289.46
Oct 16, 2026
52-week range
$218.31 — $329.16
-12% from high
Market cap
104.1B
Diluted basis
Dividend yield
1.8%
P/E
24.6
Trailing
Verdict status · Oct 16, 2026

Not yet scored

Filing.fyi has not computed forensic scores for CME yet. Scores appear after the company's next data refresh.

No verdict yet
RED DEEP Scores pending shown after the next data refresh
Composite Health
AI synthesis · written from this company's SEC filings · not investment advice

What the filing actually says.

AI · forensic preset

The data provided here includes no forensic scores (Beneish M-Score, Piotroski F-Score, Altman Z-Score, or Fog Index), so this synthesis does not assess any score, and no score-based conclusion can be drawn from the figures below. On the annual numbers, 2025 revenues of $6.52 billion rose about 6.4% from $6.13 billion, and net income of $4.07 billion rose about 15% from $3.53 billion. Operating income grew more slowly, about 7.6% to $4.23 billion from $3.93 billion, so net income grew faster than operating income in 2025. The excerpts do not show the components of that difference. The Q1 2026 MD&A shows a similar pattern: non-operating income rose 47% to $201.2 million, while net income grew 21% to $1,154.3 million. Readers may want to look at the non-operating line in the full filings to see what drove it. Management's explanations for volume growth rely heavily on the Middle East conflict and Federal Reserve policy uncertainty. The filing does not quantify how much of the Q1 gain is likely to persist. Cash flow from operating activities rose 13% to $1,259.9 million in Q1 2026. Regulatory exposure is also material. CME is designated a systemically important financial market utility and a systemically important derivatives clearing organization, and the FanDuel prediction markets joint venture operates as a registered futures commission merchant. The planned securities clearing launch later in 2026, starting with cash U.S. Treasury and repo transactions, adds competition against FICC and ICE Clear Credit's Treasury Clearing Service. Because the risk factor and MD&A excerpts are truncated, readers may want to look at the complete Item 1A and the full cash markets discussion before drawing conclusions.

Catalyst.Total revenues for the quarter ended March 31, 2026 were $1,880.1 million, up 14% from $1,642.3 million a year earlier. Clearing and transaction fees rose 15% to $1,542.6 million, and market data and information services rose 15% to $224.1 million. Futures and options contract volume reached 2,210.1 million round turns, up 22%. Management attributes the volume increase mainly to the Middle East conflict and uncertainty over Federal Reserve interest rate policy, which it says lifted activity across interest rate, equity index, energy, and metals products. Average daily volume in interest rate products rose 24%, and metals volume rose 130%, led by gold and silver.

Hidden risk.The average rate per contract fell 5% to $0.652 from $0.686. Management says the decline came largely from growth in micro contracts, which carry lower rates, and from volume-based incentives. The filing estimates that the rate decline reduced clearing and transaction fees by $59.8 million, offsetting most of the $257.5 million gained from higher volume. Volume that depends on market volatility may fall when conditions calm. The risk factors also describe competition from ICE, Cboe, Euronext, prediction markets, and lower-priced rivals targeting the EBS and BrokerTec cash markets.

Market signals · from trading data, not filings

What traders are betting.

The scores above come from what CME reports to the SEC. These readings come from how traders are positioned in its shares. They change quickly, they can be wrong, and they are not part of the verdict.
Short interest Shares sold short · reported twice a month
1.7%
of the shares available to trade
Low
0%5% · 10% · 20%25%+

The metric

Shares that traders have borrowed and sold, betting the price will fall, and not yet bought back. Brokers report the total to FINRA twice a month. Days to cover divides it by the shares that change hands on a typical day.

Shares sold short
5.5M
Change since Aug 31
−1.8%
Days to cover
3.0

What it tells us

Few traders are betting against CME. Levels this low are common for large, widely held companies.

Little changed since the Aug 31 report (−1.8%).

At normal trading volume, short sellers would need about 3.0 days to buy back every borrowed share.

How investors use it

  • Squeeze watching. Some aggressive traders seek out heavily shorted stocks, betting that good news will force short sellers to buy back shares and push the price higher.
  • Hedging. Funds short one company to offset risk in another, often owning a stronger business and shorting a weaker one in the same industry.
  • Timing. Chart-based traders pair rising short interest with price patterns, such as a break below a level where buyers used to step in, to decide when to enter or exit.
  • Warning sign. Some owners treat a sharp rise in short interest as a red flag and respond by tightening stop-loss orders or holding smaller positions.

Lesson: short interest, explained →

Short-interest report for Sep 30, 2026, via Yahoo Finance. Reports come out about a week and a half after that date.

SEC filings · last 12 months

Annual report, quarterly reports & proxy statement

The annual report (10-K), quarterly reports (10-Q), proxy statement (DEF 14A) and current reports (8-K) CME Group filed in the last 12 months, each linked to the original document on SEC EDGAR.

  • Sep 25, 2026
    8-K
    Current reportItem 5.03: Charter or bylaw change; fiscal-year change
    ★ Curriculum-relevant
    EDGAR →
  • Sep 9, 2026
    8-K
    Current reportItem 5.02: Departure/appointment of officers or directors
    ★ Curriculum-relevant
    EDGAR →
  • Aug 11, 2026
    8-K
    Current reportItem 7.01: Regulation FD disclosure (investor materials)0
    EDGAR →
  • Jul 24, 2026
    10-Q
    Quarterly report0
    EDGAR →
  • Jul 22, 2026
    8-K
    Current reportItem 2.02: Results of operations (earnings)0
    EDGAR →
  • Apr 27, 2026
    8-K
    Current report (2026-04-22)Item 1.01: Signed a material agreement0
    EDGAR →
  • Apr 24, 2026
    10-Q
    Quarterly report (2026-03-31)Period: 2026-03-310
    EDGAR →
  • Apr 22, 2026
    8-K
    Current report (2026-04-22)Item 9.01 Financial Statements and Exhibits . Exhibit Number Description 99.1 Press Release, dated April 22, 202 6 . 104 The cover page from CME Group Inc.'s Cu0
    EDGAR →
  • Mar 23, 2026
    DEF 14A
    Proxy statement (2025-12-31)0
    EDGAR →
  • Feb 26, 2026
    10-K
    Annual report (2025-12-31)Period: 2025-12-310
    EDGAR →
  • Feb 4, 2026
    8-K
    Current report (2026-02-04)Item 9.01 Financial Statements and Exhibits . Exhibit Number Description 99.1 Press Release, dated February 4 , 202 6 . 104 The cover page from CME Group Inc.'s0
    EDGAR →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →